Latest Breaking News On - Novartis pharmaceuticals canada - Page 1 : comparemela.com

MorphoSys stock gains after Novartis discloses all tender offer conditions were met

MorphoSys stock gains after Novartis discloses all tender offer conditions were met
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Novartis pharmaceuticals canada incNovartis pharmaceuticals canadaStock editorial

University Hospital Foundation, AHS join together to tackle heart disease

University Hospital Foundation, AHS join together to tackle heart disease
edmontonsun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from edmontonsun.com Daily Mail and Mail on Sunday newspapers.

Sherwood parkGrande prairieNew yorkUnited statesUniversity hospitalZach hymanGary semeniukDanielle smithRamin ostadAdriana lagrangeJodi abbottRyan nugent hopkinsNovartis pharmaceuticals canadaUniversity hospital foundationAlberta health servicesEdmonton university hospital foundation

INNODEM NEUROSCIENCES ETNAtm-MS OBTAINS HEALTH CANADA S APPROVAL

INNODEM NEUROSCIENCES ETNAtm-MS OBTAINS HEALTH CANADA S APPROVAL
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Erin keithInnodem neurosciencesMarc reevesNeuroscience at novartis pharmaceuticals canada incHealth canadaNovartis pharmaceuticals canada incEye tracking neurological assessmentMultiple sclerosisExpanded disability status scalePad proChief business officerChief executive officerNovartis pharmaceuticals canadaVice president

INNODEM NEUROSCIENCES ETNA™-MS OBTAINS HEALTH CANADA S APPROVAL

Innodem Neurosciences, a leading digital health and AI company, announced today that its ETNA™-MS has been cleared for commercial use by Health Canada. The Eye Tracking Neurological Assessment for Multiple Sclerosis (ETNA™-MS) is a software as a medical device (SaMD, Class II) intended to administer a non-invasive test and provide an Expanded Disability Status Scale (EDSS) score in the range between 1.0 and 4.5 for use in tracking disease progression in MS patients.

Innodem neurosciencesMarc reevesErin keithNovartis pharmaceuticals canada incNeuroscience at novartis pharmaceuticals canada incPad proChief business officerChief executive officerNovartis pharmaceuticals canadaVice presidentEye tracking neurological assessmentEye movementMedical deviceHealth canadaDss scoreI company

Mark Vineis appointed as the new Country President of Novartis Canada

Novartis Canada announces that Mark Vineis has been appointed to the role of Country President, effective as of January 1, 2024. Mark brings a wealth of experience and knowledge to the organization, with more than 25 years in the industry and in a variety of leadership roles within Novartis US.

Andrea marazziClaudja josephMark vineisNovartis pharmaceuticals canada incPatient servicesPharmaceuticals access strategy commercializationCountry presidentSandoz biopharmaceuticalsVice presidentMarket accessPharmaceuticals access strategyCountry president andrea marazziNovartis pharmaceuticals canadaPharmaceuticals canadaNovartis canada